Early switch to fingolimod for achieving no evidence of multiple sclerosis disease activity: 7-year analysis of data from the TRANSFORMS study

Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 295ed03e611debb07b9456d182cd0eec92a49040
First added on: Feb 08, 2025